SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 18.60
+0.10 (0.54%)
Jul 24, 2026, 4:25 PM CET
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 984.46 million as of July 24, 2026. Its market cap has decreased by -1.11% in one year.
Market Cap
984.46M
Enterprise Value
919.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
18.60
ChartMarket Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 984.46M, an increase of 1,444.20%. That is a compound annual growth rate of 31.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 984.46M | -18.32% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Saniona AB | 1.83B |
| Flerie AB | 1.82B |
| BioInvent International AB | 1.48B |
| Genovis AB (publ.) | 1.29B |
| Medivir AB | 1.09B |
| AlzeCure Pharma AB | 910.12M |
| Infant Bacterial Therapeutics AB | 875.64M |
| Xspray Pharma AB | 740.65M |